A CONTROL STUDY OF YAVAKSHARA IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) W.S.R. TO VATASHTHEELA by M. Borkar, Kanchan et al.
        Int. J. Ayur. Pharma Research, 2013; 1(1): 60-65                        ISSN 2322 – 0910 
 Available online at : http://ijapr.in Page 60 
 
 
  International Journal of Ayurveda and Pharma Research 
Research Article 
A CONTROL STUDY OF YAVAKSHARA IN THE MANAGEMENT OF BENIGN PROSTATIC 
HYPERPLASIA (BPH) W.S.R. TO VATASHTHEELA 
Kanchan M. Borkar1*, Anantkumar V. Shekokar2, Ashish Kumar Singh3 
1*Lecturer, 2H.O.D, 3P.G. Scholar, Dept of Shalya Tantra, S.V.N.H.T’S Ayurved Mahavidyalaya, Rahuri Factory, 
Ahmednagar, Maharashtra, India. 
Received on: 22/08/2013                  Revised on: 25/08/2013                               Accepted on: 30/08/2013 
 
ABSTRACT 
In Ayuraveda, Vatashtheela is one among the 12 types of Mutraghata (obstructive uropathy) 
disorders elaborated in the Sushruta Samhita. Vatashtheela disease closely resembles Benign 
Prostatic Hyperplasia (BPH) of modern medicine in its signs and symptoms. The control study has 
been carried out in two different groups. Each group made of 30 patients. In trial group 30 patients 
treated with Yavakshara. In control group 30 patients were treated with capsule Pyginal. It contains 
Pygeum Africanum which is useful in BPH. Phytotherapy refers to use of plant extract, which is 
popular in Europe as a herbal medicine for many years & also mentioned in modern text book of 
smith urology & commonly practiced by allopathic urologist. Patient was selected randomly 
irrespective of their religion, race, occupation etc. In BPH irritative and obstructive symptoms like 
frequency, urgency, staining, weak stream, incomplete emptying, nocturia, residual urine and 
uroflow rate were observed over the month of treatment from onset of treatment. Observations 
were made & results were analyzed with the help of unpaired ‘t’ test at 0.05 level of significance. 
KEYWORDS: Benign Prostatic Hyperplasia (BPH), Astheela, Vatashtheela, Yavakshara, Pyginal, 
Nocturia.
INTRODUCTION 
 In Ayurvedic classics Mutraghata gives the 
symptoms of low urinary output either by retention, 
absolute or relative anuria or oliguria Mutraghata is 
predominantly due to the Vata Dosha1. The Vata Dosha is 
responsible to expel the urine output timely & uniformly. 
If Vata gets vitiated, it causes various diseases related to 
Basti & produces Mutraroga such as Prameha, Ashmari, 
Mutraghata, Mutrakruchcha etc.  
In Ayuraveda the Vatashtheela Vyadhi which is a 
type of Mutraghata may have some similarity with BPH 
on the basis of symptoms like Achala Unnata Granthi 
(singly movable & elevated), Vinmutranilasanga 
(retention of urine, faeces & flatus), Bastiadhmana 
(distension of the urinary bladder), 
Vedanachaparabastou (excruciating pain in the 
bladder)2. 
BPH is most common benign tumor in male, and 
its incidence is age related. Risk factor for the 
development of the BPH are poorly understood. Some 
studies have suggested genetic predisposition and some 
have noted racial differences3. BPH is a senile disorder 
and chiefly affects individuals above the age of 50 years. 
The symptoms are those of bladder outflow obstruction, 
with increased frequency of micturition, dribbling, 
hesitancy, and the features of chronic urinary retention. 
In Ayuraveda literature, Mutra ghata should be 
treated with Bhaishajya Chikitsa only. Acharya Sushruta 
decided general line of management of all type of 
Mutraghata by use of Kashaya, Kalka, Avaleha, Kshar, 
Madhya, Aasava, Swedana, Basti and Uttarbasti4 so, in 
was decided to use Paniya Kshar in the treatment of 
Vatashtheela (BPH). 
Yava or barley (fig.1) is one of the oldest of 
cultivated cereals and extensively used as food and cattle 
feed and for malting brewing and pearling. Barley is 
utilized in various purposes and it enters in several 
products of food and pharmaceutical preparations other 
than alcoholic preparations.  
Yavakshara is recommended in various diseases 
and used in indigenous medicine for treatment of certain 
aliments e.g. Udararog, Mutrakruccha, Visha, Amadosa, 
Kaphavatavikar, Amavata, and some other complaints. 
According to Bhaishajyaratnavali, Yavakshara is superior 
and best among other Kshara (alkali) as well as it can be 
used as a Lekhankarma (scraping) and having diuretic 
property5. 
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Yavakshara is Katurasa in taste and Katuvipak, 
Ushna Virya, Vata, Kaphaghna in action. While pyginal is 
a phyto therapeutic product extracted from the bark of 
“pygeum africanum Hooker”6. The extract has been used 
for treatment of bladder pains and micturation 
problems. So control study on Yavakshara and pyginal in 
the treatment of Benign Prostatic Hyperplasia 
(Vatashtheela) has been carried out. 
Aims & Objects 
1) To study etiopathogenesis, signs & symptoms of 
the BPH & Vatashtheela. 
2) To study efficacy of Yavakshara & pyginal.  
MATERIAL & METHODS 
 Present clinical study has been carried out in 
the OPD & IPD level in the Shalyatantra department 
S.V.N.H.T’s Ayurved Mahavidyalaya Rahuri provided the 
following material & were selected irrespective of their 
religion, race, occupation etc., fulfilling the selection & 
eligibility criteria & informed written consent was taken. 
Preparation of Drug 
 Trial drug Yavakshara was prepared as classical 
method mentioned in Sharangdhar Samhita7 and 
refilling of Yavakshara in a capsule form was prepared at 
S.V.N.H.T’s Ayurved Mahavidyalaya Rahuri in 
Shalyatantra department. 
Seed of Yava (barley) purchased from farmer 
and dried in sunlight. Impurities were taken out from 
Yava seeds. All the seeds were burnt (fig.2). At the end, 
burnt ash of Yava seeds was collected. This ash is 
dissolved in water (fig.3) which left for whole night & 
next day mixture filtered by cotton cloth (fig.4). The 
above process of filtration was repeated for next 21 
days. At the end of 21st day liquid containing fine ash of 
Kshara obtained. The liquid was heated on furnace 
(fig.5), at the base of pot got fine ash of Kshara, this fine 
ash called Yavakshara (fig.6), capsules are prepared in 
the dose 500mg. (fig.7) Yavakshara was sent for 
standardization in research laboratory.  
Table 1: Standardization of Yavakshara 
Description White coloured, crystalline, 
coarse powder 
PH (10% solution) 4.74 
Assay for potassium (K) 23.4437% 
Assay for Sodium (Na) 0.0843% 
 Control drug capsule Pyginal 50mg (fig.8) was 
purchased from serum Institute of India Ltd., medical 
store of S.V.N.H.T’s Ayurved Mahavidyalaya Rahuri. 
Table 2: Course of administration 
 Capsule containing 
Yavakshara Pyginal 
Dose 500mg BD orally 50mg BD orally 
Time of 
administration 
Before meal  After meal 
 Anupana Koshnajal Koshnajal 
 Duration 1 month  1 month 
 Total number of 60 patients were studied. 
 Group A- 30 patients was treated with capsule 
Yavakshara as a trial group. 
 Group B -30 patients was treated with capsule Pyginal. 
Laboratory Investigation 
1. Complete blood count  
2. Sr. Creatinine  
3. Urine Routine & microscopic  
4. Blood Urea  
5. Prostate Specific Antigen (If Required)  
6. Ultra Sonography 
Physical examination 
1) Measurement of residual urine by catheterization  
2) Uroflowmetry  
3) Digital rectal examination  
Inclusion criteria 
1) Patient age group of 50-80 year.  
2) Patient with mild and moderate symptoms according 
to questionnaire for American urological association 
score given for BPH. 
3) Patients of Samanya Lakshana’s of Vatashtheela. 
Exclusion of criteria 
1) Patient having acute urinary retention, stricture of 
urethra, Ca. prostate, congenital contracture of bladder 
neck, bladder polyps, cystitis, Hydronephrosis, 
Urolithiasis. 
2) Patient with severe systemic disease like cardiac 
disease, Diabetes Mellitus, Renal failure, HIV-Immuno-
compromised patients must be excluded. 
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Table 3: Criteria of Assessment8 
 Urinary Symptoms Observed Over The 
Month Of Treatment From Onset Of 
Treatment 
Grade-0 Grade-1 Grade-2 Grade-3 Grade-4 
1.  Frequency- how many times patient have 
to urinate again less than 2hrs.after 
finishing urination 
Not at all Less than 7 
days 
7-15 
days 
16-21 days Almost 
always 
2.  Urgency- how many times patient found 
difficulty to postponed urination 
Not at all Less than 7 
days 
7-15 
days 
16-21 days Almost 
always 
3.  Straining- how many times patient have 
to strain to begin urination. 
Not at all Less than 7 
days 
7-15 
days 
16-21 days Almost 
always 
4.  Weak Stream- how many times patient 
found weak urinary stream. 
Not at all Less than 7 
days 
7-15 
days 
16-21 days Almost 
always 
5.  Incomplete Emptying- how many times 
patient have sensation of not emptying 
bladder completely after finishing urine. 
Not at all Less than 7 
days 
7-15 
days 
16-21 days Almost 
always 
6.  Nocturia- how many times patient got up 
to urinate 
0-1 Time 2-3 Time 4-5 
Times 
6-7 Times More than 7 
Times 
Assessment of Residual Urine 
Grade I  - 0 to 50 ml. 
Grade II - 51 to 100 ml. 
Grade III -  101 to 150 ml. 
Grade IV -  151 to 200 ml. 
Assessment of Urine Flow Rate 
Grade I   -  15 ml. 
Grade II  -  12 to14 ml. 
Grade III  -  09 to 11 ml. 
Grade IV  -  06 to 08 ml. 
Grade V   -  less than 06 ml. 
Obtained Results have been discussed and analyzed on 
following parameters. 
1. Complete Relief  - 100% relief. 
2. Markedly improvement -  more than 50% relief. 
3. Improvement  -  25-50% relief. 
4. Unchanged   -  upto 25% relief. 
Follow up study: 7th day -15th day -21st day -30th days. 
OBSERVATION & RESULTS 
Table 4: % of Relief According to symptom methodology for Group- A. & Group-B 
S. 
NO. 
Clinical Feature Group-A Group-B 
No.of.pt. % of relief No.of.pt. % of Relief 
t.val P<0.05 % of 
relief 
t.val P<0.05 % of 
relief 
1. Urgency 30 9.12 H.S 65 30 6.53 H.S 63 
2. Frequency 30 8.92 H.S 54 30 14.39 H.S 64 
3. Straining 30 6.03 H.S 61 30 7.10 H.S 32 
4. Weak stream 30 2.36 H.S 57 30 14.16 H.S 21 
5. Incomplete Emptying 30 3.29 H.S 69 30 10.71 H.S 23 
6. Nocturia 30 4.98 H.S 66 30 9.17 H.S 51 
7. Residual urine 30 14.01 H.S 55 30 7.99 H.S 37 
8. Uroflow rate 30 7.99 H.S 30 30 6.79 H.S 39 
(H.S Highly Significant) 
Effect of Therapy 
Result Group-A Group-B 
Cured 00 00 
Markedly Improved 10 25 
Improved 20 05 
Unchanged 00 00 
 
DISCUSSION 
BPH is a common ailment of elderly population 
and an advisable treatment of choice is surgery, which is 
mentally & physically painful. Due to number of 
complications of operative surgery in old age, old 
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persons avoid operative treatment for their BPH 
symptoms & seeking a safe & effective treatment for 
easy life. In this situation, the medicinal treatment may 
play an important role. 
Hence to avoid surgery and its complication, 
Yavakshara can be used as a medicinal treatment and its 
action can be given as Ushna, Tikshna Guna of 
Yavakshara causes Lekhana Karma of Mamsavaha Srotas 
i.e. it reduces the size of hypertrophied prostate gland 
which relieves urgency & frequency. 
Vitiated Vata Dosha creates Kapha Pitta Dushti 
because of Vishamagni. Ama formed due to Vishamagni 
settled at Basti causes Vatashtheela. Above all Samprapti 
Vishamagni plays important role & Yavakshara causes 
Agnideepan due to its Ushna, Tikshna Guna. Also Ushna 
Tikshna Guna of Yavakshara causes Strotovivaran & 
Strotoshodhan8 so weak stream, incomplete emptying of 
bladder, nocturia decreases. 
Pyginal is a natural association of substances 
like Phytosterols, Pentacyclic tritepenes and Ferulic acid 
Esters of fatty alcohols, with synergistic pharmacological 
effects on prostrate. These constituents are endowed 
with anti-inflammatory, antiedema and cholesterol 
lowering action on prostate9.  
CONCLUSION 
Use of Yavakshara for BPH can prolong the 
surgical treatment. Use of Yavakshara in early stage of 
BPH can prevent the further progressive pathology of 
disease. Yavakshara gives symptomatic relief in irritative 
symptoms like urgency, frequency, nocturia while in 
straining, weak stream and incomplete emptying of 
bladder, Yavakshara shows less significant effect as 
these symptoms are obstructive in nature. Pyginal have 
shown markedly improvement in obstructive and 
irritative pathology of BPH. Most of the patients having 
associate symptoms i.e. constipation and Yavakshara 
shown marked improvement for constipation while 
pyginal does not show any relief in constipation. 
ACKNOWLEDGEMENT 
 The author wish to thank Prof. P.R. Adhav, 
Principal, S.V.N.H. Ayurved college Rahuri. & Dr.V.D. 
Patange, Assistant Professor, Dept of Dravyaguna, S.C.M. 
Aryangla Mahavidyalaya, Satara (M.S). 
 
REFERENCES 
1. Sushrut Samhita, Dr. Anantram Sharma, 
Sushrutvimarshini, hindi commentary, Vol. III, 
mutraghatapratishedhadhyaya, uttartantra 
aadhyaya no. 58, sutra no. 5-8; Page No. 474, 
Chaukhamba Surbharati Prakashan, Varanasi 1st 
edition, 2001. 
2. Prof. G.D. Singhal & Colleagues, Susruta-Samhita 
Ancient Indian Surgery, Chaukhamba Sanskrit 
Pratishthan, Delhi. Reprint: 2007: Vol: 3; Page No: 
443. 
3. Smith’s general urology, Emil A. Tanagho and Jack 
W. McAninch, vol. I, chapter no. 23, pg. no. 399, 
McGraw-Hill companies, new Delhi, international 
15th edition 
4. Sushrut Samhita, Dr. Anantram Sharma, 
Sushrutvimarshini hindi commentary, Vol.II, 
ashmarichikitsaadhyaya, chikitsasthan aadhyaya no. 
07, sutra no. 27; Page No. 237, Chaukhamba 
Surbharati Prakashan, Varanasi 1st edition, 2001. 
5. Bhaishjyaratnavali, kaviraj shri ambikadatta shastri, 
vidyotini hindi vyakhya, 
mutrakruchchachikitsaprakaranam, adhya no. 34, 
sutra no. 15, Page no. 493, Chaukhamba sanskrit 
samsthan, Varansi, 2nd edition, 2002. 
6. Smith’s general urology, Emil A. Tanagho and Jack 
W. McAninch, vol. I, chapter no. 23, pg. no. 404, 
McGraw-Hill companies, new Delhi, international 
15th edition 
7. Sharangadhara Samhita Dr. Brahmanand Tripathi, 
dipika, hindi commentary, madhyamkhand, 
ekadashoadhyaya, sutra no. 102 Page no. 282, 
Chaukhamba Surbharti Prakashan Varanasi, 2nd 
edition 1990. 
8. Smith’s general urology, Emil A. Tanagho and Jack 
W. McAninch, vol. I, chapter no. 23, pg. no. 402, 
McGraw-Hill companies, new Delhi, international 
15th edition 
9. Bhavprakash Nighantu, shri bhramhashankar 
shastri, vidyotini hindi vyakhya, poorvardha, 
haritakyadivarga, sutra no. 255, Page no.193, 
Chaukhamba Sanskrit samsthan, Varanasi, 1st 
edition 1984. 
10. http://www.seruminstitute.com/content/products/
product_pyginal.htm Date: 8/9/2011, 3.00 PM 
 
  
  
*Address for correspondence 
Dr Kanchan M Borkar 
Lecturer, Dept of Shalya Tantra 
S.V.N.H.T’S Ayurved Mahavidyalaya, Rahuri 
Factory, Ahmednagar, Maharashtra, India. 
Cell: +919960299306 
drkanchanborkar@gmail.com 
Cite this article as:  
Kanchan M. Borkar, Anantkumar V. Shekokar Ashish Kumar 
Singh. A Control Study of Yavakshara in the Management of 
Benign Prostatic Hyperplasia (BPH) w.s.r. to Vatashtheela. 
Int. J. Ayur. Pharma Research 2013; 1 (1): 60-65. 
Source of support: Nil, Conflict of interest: None Declared 
 
                                                            Int. J. Ayur. Pharma Research, 2013; 1(1): 60-65                                        ISSN 2322 - 0910 
 Available online at : http://ijapr.in Page 64 
 
PHOTOGRAPHS 
                          
                 Figure 1. Yava (barley)             Figure 2. Burning of Yava 
 
 
                          
                       Figure 3. Dissolution of Ash                         Figure 4. Filteration of Mixture 
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                    Figure 5. Heating Process                                                                  Figure 6. Prepared Yava kshara 
 
 
  
       Figure7. Prepared Yava kshara Capsule                  Figure 8. Pyginal Capsule 
 
 
 
 
 
 
 
 
 
 
 
 
